These concepts reframed a practical clinical problem: implants are often manufactured, packaged, shipped, and stored for substantial periods before clinical use
GLP-1 medications are most effective when paired with healthy eating, regular physical activity, and behavioral changes
Non-injectable semaglutide offers easier administration for individuals with needle sensitivity or physical limitations
Stay well hydrated to replace lost fluids and electrolytes
95% CI, 0.67-1.46)
Recientemente, orforglipron , un agonista oral del receptor GLP-1 , ha mostrado potencial en estudios de fase 3 que finalizarn en 2027, ofreciendo una alternativa que podra mejorar la adherencia al tratamiento, dado que muchos pacientes prefieren no inyectarse medicamentos